Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 How Should Clinicians Respond When Patients’ Loved Ones Do Not See “Brain Death” as Death? Rabbi Jason Weiner, DBioethics and Rabbi Charles Sheer, MA, BCC Religious and cultural values can conflict with clinical standard practice and law. AMA J Ethics. 2020;22(12):E995-1003. doi: 10.1001/amajethics.2020.995. Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010. Podcast Nov 2020 Ethics Talk: Managing Health Care AI “Megarisks” Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves. Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175. State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711. Viewpoint Jan 2022 How Medical-Dental EHR Integration Can Improve Diabetes Care Neel Shimpi, BDS, MM, PhD, Elizabeth Buchanan, PhD, and Amit Acharya, BDS, MS, PhD Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General. AMA J Ethics. 2022;24(1):E99-105. doi: 10.1001/amajethics.2022.99. Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. History of Medicine Nov 2017 How Co-Creation Helped Address Hierarchy, Overwhelmed Patients, and Conflicts of Interest in Health Care Quality and Safety Sigal Israilov and Hyung J. Cho, MD Co-creative health systems planning requires engaging patients and learning from peers. AMA J Ethics. 2017;19(11):1139-1145. doi: 10.1001/journalofethics.2017.19.11.mhst1-1711. State of the Art and Science Nov 2020 How Might Artificial Intelligence Applications Impact Risk Management? John Banja, PhD AI models might advance human welfare in unprecedented ways, but progress will not occur without substantial risks that will have to be managed. AMA J Ethics. 2020;22(11):E945-951. doi: 10.1001/amajethics.2020.945. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Dec 2020 How Should Clinicians Respond When Patients’ Loved Ones Do Not See “Brain Death” as Death? Rabbi Jason Weiner, DBioethics and Rabbi Charles Sheer, MA, BCC Religious and cultural values can conflict with clinical standard practice and law. AMA J Ethics. 2020;22(12):E995-1003. doi: 10.1001/amajethics.2020.995.
Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010.
Podcast Nov 2020 Ethics Talk: Managing Health Care AI “Megarisks” Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves.
Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175.
State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711.
Viewpoint Jan 2022 How Medical-Dental EHR Integration Can Improve Diabetes Care Neel Shimpi, BDS, MM, PhD, Elizabeth Buchanan, PhD, and Amit Acharya, BDS, MS, PhD Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General. AMA J Ethics. 2022;24(1):E99-105. doi: 10.1001/amajethics.2022.99.
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.
History of Medicine Nov 2017 How Co-Creation Helped Address Hierarchy, Overwhelmed Patients, and Conflicts of Interest in Health Care Quality and Safety Sigal Israilov and Hyung J. Cho, MD Co-creative health systems planning requires engaging patients and learning from peers. AMA J Ethics. 2017;19(11):1139-1145. doi: 10.1001/journalofethics.2017.19.11.mhst1-1711.
State of the Art and Science Nov 2020 How Might Artificial Intelligence Applications Impact Risk Management? John Banja, PhD AI models might advance human welfare in unprecedented ways, but progress will not occur without substantial risks that will have to be managed. AMA J Ethics. 2020;22(11):E945-951. doi: 10.1001/amajethics.2020.945.